Globeflex Capital L P Invests $623,000 in Ralliant Corporation $RAL

Globeflex Capital L P purchased a new position in shares of Ralliant Corporation (NYSE:RAL) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 8,461 shares of the company’s stock, valued at approximately $623,000.

A number of other large investors also recently bought and sold shares of the business. First Nebraska Trust Co purchased a new position in Ralliant during the 2nd quarter valued at $760,000. Bank of Nova Scotia purchased a new stake in Ralliant in the second quarter worth $16,964,000. Commerce Bank purchased a new stake in Ralliant in the second quarter worth $748,000. Quantbot Technologies LP bought a new stake in shares of Ralliant during the second quarter worth $5,301,000. Finally, Evolve Private Wealth LLC bought a new stake in shares of Ralliant during the second quarter worth $209,000.

Analyst Ratings Changes

RAL has been the subject of a number of recent analyst reports. TD Cowen boosted their target price on shares of Ralliant from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a research note on Friday, July 31st. BMO Capital Markets started coverage on shares of Ralliant in a report on Monday, July 20th. They set a “market perform” rating and a $78.00 price objective for the company. Royal Bank Of Canada boosted their price objective on shares of Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research report on Friday, July 31st. Finally, Evercore initiated coverage on shares of Ralliant in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $75.70.

Ralliant Trading Down 1.7%

Shares of NYSE RAL opened at $61.87 on Wednesday. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $75.41. The firm has a market cap of $6.85 billion, a PE ratio of -5.70, a price-to-earnings-growth ratio of 2.34 and a beta of 1.60. The business has a fifty day simple moving average of $68.69 and a two-hundred day simple moving average of $56.04. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.75.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a positive return on equity of 14.97% and a negative net margin of 56.38%.The business had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. Ralliant’s dividend payout ratio is -1.84%.

Insider Transactions at Ralliant

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $71.79, for a total transaction of $928,675.44. Following the transaction, the chief executive officer owned 251,967 shares of the company’s stock, valued at approximately $18,088,710.93. This trade represents a 4.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $72.00, for a total transaction of $436,464.00. Following the completion of the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This represents a 16.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by corporate insiders.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.